Pavilion Health Today
Supporting healthcare professionals to deliver the best patient care

Cholinesterase inhibitors in Alzheimer’s disease €” an update

bs_subtitle

Alzheimer’s disease affects an ever growing number of people, with almost half a million patients in the UK alone. Unfortunately approaches to treating Alzheimer’s disease are limited and cholinesterase inhibitors are the most commonly used agents.

Comments are closed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more ...

Privacy & Cookies Policy